This week, we are going to discuss a condition that occurs after trauma and surgery as well as after traumatic injuries to the head, neck and spine. The condition? Heterotopic ossification.

- Initial NHHO study targets patients with traumatic SCI who have high rates of HO, which causes abnormal bone growth in soft tissues - BRISBANE, Calif.--(BUSINESS WIRE)--āshibio, a privately held, ...

Proposed model for Regulation of BMP Activity by DDR2. After binding collagen, DDR2 alone or together with collagen-binding β1 integrins stabilizes YAP/TAZ nuclear accumulation. This is accomplished ...

The US Food and Drug Administration (FDA) has approved palovarotene (Sohonos), the first-ever treatment for people with the rare and severely disabling bone condition fibrodysplasia ossificans ...

The FDA approved the oral retinoid palovarotene (Sohonos) for treating abnormal bone growth associated with fibrodysplasia ossificans progressiva (FOP), drugmaker Ipsen announced on Wednesday.

Please provide your email address to receive an email when new articles are posted on . Surgical treatment of thoracic ossification of the posterior longitudinal ligament yielded positive long-term ...

We have identified a macrophage population "Mrep" that plays an essential role in muscle repair. However, in Fibrodysplasia ossificans progressiva (FOP), Mrep functions as a pathogenic cell that ...